Paul Vet Healthcare Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 17-06-2024
- Paid Up Capital ₹ 0.37 M
as on 17-06-2024
- Company Age 19 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 5.95 M
as on 17-06-2024
- Revenue 18.89%
(FY 2023)
- Profit 63.77%
(FY 2023)
- Ebitda -16.98%
(FY 2023)
- Net Worth 7.46%
(FY 2023)
- Total Assets -0.21%
(FY 2023)
About Paul Vet Healthcare
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.37 M.
The company has closed loans amounting to ₹5.95 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Renuka Chandra and Prem Chandra serve as directors at the Company.
- CIN/LLPIN
U24231DL2005PTC134671
- Company No.
134671
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Apr 2005
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Paul Vet Healthcare Private Limited offer?
Paul Vet Healthcare Private Limited offers a wide range of products and services, including Animal Medicines & Health Care, Veterinary Medicines, Bird Food, Poultry & Animal Food, Animal Feed Supplement.
Who are the key members and board of directors at Paul Vet Healthcare?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Prem Chandra  | Director | 04-Apr-2005 | Current |
| Renuka Chandra | Director | 04-Apr-2005 | Current |
Financial Performance of Paul Vet Healthcare.
Paul Vet Healthcare Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 18.89% increase. The company also saw a substantial improvement in profitability, with a 63.77% increase in profit. The company's net worth moved up by a moderate rise of 7.46%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Paul Vet Healthcare?
In 2023, Paul Vet Healthcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 19 Jun 2015 | ₹0.25 M | Satisfied |
Allahabad Bank Creation Date: 22 Jan 2014 | ₹1.00 M | Satisfied |
Others Creation Date: 27 Jul 2013 | ₹4.70 M | Satisfied |
How Many Employees Work at Paul Vet Healthcare?
Unlock and access historical data on people associated with Paul Vet Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Paul Vet Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Paul Vet Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
